Investor Presentation via Investor Meet Company

Summary by AI ^BETAClose X

International Biotechnology Trust PLC announced that Ailsa Craig and Marek Poszepczynski will present the company's results for the six months ended 28 February 2026 via Investor Meet Company on Tuesday, 12 May 2026, at 09:00 am BST. This presentation is accessible to all current and potential investors, with the ability to submit questions either before the meeting or during the live session.

Disclaimer*

Intl. Biotechnology Trust PLC

06 May 2026

INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")

Investor Presentation via Investor Meet Company

International Biotechnology Trust plc is pleased to announce that Ailsa Craig and Marek Poszepczynski will provide a live presentation on the Company's results for the six months ended 28 February 2026 via the Investor Meet Company platform on Tuesday 12 May 2026 at 09:00 am BST.

The presentation is open to all existing and potential investors. Questions can be submitted pre-event via your Investor Meet Company dashboard before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet INTERNATIONAL BIOTECHNOLOGY TRUST PLC via:

https://www.investormeetcompany.com/international-biotechnology-trust-plc/register-investor

Investors who already follow INTERNATIONAL BIOTECHNOLOGY TRUST PLC on the Investor Meet Company platform will automatically be invited.

ENDS

Enquiries:

Schroder Investment Management Limited

Charlotte Banks (Press)

Kirsty Preston

Natalia de Sousa/ Michelle Taiwo (Company Secretary)

020 7658 6000

Kaso Legg Communications (Financial PR)

Charles Gorman

Henry Taylor

Effie Aye Maung Hider

IBT@kl-communications.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END